- Home
- FSFG vs GALT Comparison
FSFG vs GALT Comparison
Compare FSFG & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSFG
- GALT
- Stock Information
- Founded
- FSFG 2008
- GALT 2000
- Country
- FSFG United States
- GALT United States
- Employees
- FSFG N/A
- GALT N/A
- Industry
- FSFG Savings Institutions
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- FSFG Finance
- GALT Health Care
- Exchange
- FSFG Nasdaq
- GALT Nasdaq
- Market Cap
- FSFG 210.3M
- GALT 232.3M
- IPO Year
- FSFG 2008
- GALT N/A
- Fundamental
- Price
- FSFG $30.72
- GALT $5.49
- Analyst Decision
- FSFG Strong Buy
- GALT Strong Buy
- Analyst Count
- FSFG 3
- GALT 3
- Target Price
- FSFG $31.50
- GALT $6.00
- AVG Volume (30 Days)
- FSFG 12.3K
- GALT 443.8K
- Earning Date
- FSFG 10-29-2025
- GALT 11-14-2025
- Dividend Yield
- FSFG 2.07%
- GALT N/A
- EPS Growth
- FSFG 67.68
- GALT N/A
- EPS
- FSFG 3.32
- GALT N/A
- Revenue
- FSFG $83,825,000.00
- GALT N/A
- Revenue This Year
- FSFG N/A
- GALT N/A
- Revenue Next Year
- FSFG N/A
- GALT N/A
- P/E Ratio
- FSFG $9.31
- GALT N/A
- Revenue Growth
- FSFG 23.11
- GALT N/A
- 52 Week Low
- FSFG $21.63
- GALT $0.73
- 52 Week High
- FSFG $33.00
- GALT $6.55
- Technical
- Relative Strength Index (RSI)
- FSFG 56.53
- GALT 51.59
- Support Level
- FSFG $29.06
- GALT $5.23
- Resistance Level
- FSFG $31.00
- GALT $6.32
- Average True Range (ATR)
- FSFG 0.61
- GALT 0.55
- MACD
- FSFG 0.06
- GALT -0.05
- Stochastic Oscillator
- FSFG 87.16
- GALT 36.22
About FSFG First Savings Financial Group Inc.
First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.